The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Abstract
Somatic cell nuclear transfer allows trans-acting factors present in the mammalian oocyte to reprogram somatic cell nuclei to an undifferentiated state. We show that four factors ( OCT4, SOX2, NANOG , and LIN28 ) are sufficient to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem (ES) cells. These induced pluripotent human stem cells have normal karyotypes, express telomerase activity, express cell surface markers and genes that characterize human ES cells, and maintain the developmental potential to differentiate into advanced derivatives of all three primary germ layers. Such induced pluripotent human cell lines should be useful in the production of new disease models and in drug development, as well as for applications in transplantation medicine, once technical limitations (for example, mutation through viral integration) are eliminated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Retro/lentiviruses have enabled genetic approaches in cultured primary cells to ectopically express genes of interest (1–6).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Viral screens using focused overexpression libraries can identify putative reprogramming factors, for example, by identifying a defined set of transcription factors that are selectively required to induce pluripotent stem cells (2–4,7) or trans-differentiate from mature somatic cell into another mature somatic cell (1,8–11).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Despite the power of viral technologies, pooled screens for cell reprogramming have generally adopted a one-by-one elimination approach or testing for exhaustive combinations and interrogating phenotypes in cell culture from transgenic mice (1,3,10) and/or aberrantly cloned cell lines (12).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Successful transformation of human somatic cells into iPSCs was first carried out in 2007 using a lentiviral system [95].”
From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [95]
In the citing paper
“It has been shown that NANOG and LIN28 in combination with SOX2 and OCT4 can reprogram human somatic cells into iPS cells 30 by increasing reprogramming efficiency by 76-fold 60 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [30]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Self-citationThe ENCODE Project Consortium (2007) · Nature · doi:10.1038/nature05874 · Cited by 5,223
Viable offspring derived from fetal and adult mammalian cells
Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J., & Campbell, K. H. S. (1997) · Nature · doi:10.1038/385810a0 · Cited by 4,969
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells
Meissner, A., Wernig, M., & Jaenisch, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1335 · Cited by 763
Homologous recombination in human embryonic stem cells
Zwaka, T. P., & Thomson, J. A. (2003) · Nature Biotechnology · doi:10.1038/nbt788 · Cited by 666
Self-citationVodyanik, M. A., Bork, J. A., Thomson, J. A., & Slukvin, I. I. (2005) · Blood · doi:10.1182/blood-2004-04-1649 · Cited by 619
Self-citation
Cited by
Items 201–300 of 1,132
Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications
Liu, G., David, B. T., Trawczynski, M., & Fessler, R. G. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09935-x · Cited by 519
“Human iPSCs generated from fibroblasts using retrovirus and lentivirus (Takahashi et al. 2007, Yu et al. 2007).”
BackgroundMethodResultCombinatorial development of biomaterials for clonal growth of human pluripotent stem cells
Mei, Y., Saha, K., Bogatyrev, S. R., Yang, J., Hook, A. L., Kalcioglu, Z. I., Cho, S.-W., Mitalipova, M., Pyzocha, N., Rojas, F., et al. (2010) · Nature Materials · doi:10.1038/nmat2812 · Cited by 544
“…methods to grow hES and hiPS cells include growing them on a “feeder” cell layer of mitotically-inactivated mouse embryo fibroblasts (mEFs) 1 - 3 , 6 , and on “feeder-free” culture systems, composed of a variety of extracellular matrix (ECM)/serum proteins coated onto tissue culture dishes 7…”
Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications
Mathur, A., Loskill, P., Shao, K., Huebsch, N., Hong, S., Marcus, S. G., Marks, N., Mandegar, M., Conklin, B. R., Lee, L. P., et al. (2015) · Scientific Reports · doi:10.1038/srep08883 · Cited by 519
Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs
Kim, C., Wong, J., Wen, J., Wang, S., Wang, C., Spiering, S., Kan, N. G., Forcales, S., Puri, P. L., Leone, T. C., et al. (2013) · Nature · doi:10.1038/nature11799 · Cited by 530
“Because the major metabolic differences between embryonic and adult cardiomyocytes are (1) embryonic cardiomyocytes use mostly glycolysis for energy production, and (2) adult cardiomyocytes produce most energy via fatty acid oxidation (FAO) but retain capacity to readily switch to glucose or other substrate utilizatio…”
Methods for making induced pluripotent stem cells: reprogramming à la carte
González, F., Boué, S., & Belmonte, J. C. I. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2937 · Cited by 508
“, or vary the number, identity and delivery mode of the reprogramming factor”
BackgroundAdenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells
Zhou, W., & Freed, C. R. (2009) · Stem Cells · doi:10.1002/stem.201 · Cited by 538
HIF Induces Human Embryonic Stem Cell Markers in Cancer Cells
Mathieu, J., Zhang, Z., Zhou, W., Wang, A. J., Heddleston, J. M., Pinna, C. M. A., Hubaud, A., Stadler, B., Choi, M., Bar, M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3320 · Cited by 508
Stem-cell-based therapy and lessons from the heart
Passier, R., van Laake, L. W., & Mummery, C. L. (2008) · Nature · doi:10.1038/nature07040 · Cited by 525
A comparison of non-integrating reprogramming methods
Schlaeger, T. M., Daheron, L., Brickler, T. R., Entwisle, S., Chan, K., Cianci, A., DeVine, A., Ettenger, A., Fitzgerald, K., Godfrey, M., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3070 · Cited by 510
Elite and stochastic models for induced pluripotent stem cell generation
Yamanaka, S. (2009) · Nature · doi:10.1038/nature08180 · Cited by 515
Human organoids in basic research and clinical applications
Tang, X.-Y., Wu, S., Wang, D., Chu, C., Hong, Y., Tao, M., Hu, H., Xu, M., Guo, X., & Liu, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01024-9 · Cited by 484
Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells
Sun, N., Panetta, N. J., Gupta, D. M., Wilson, K. D., Lee, A., Jia, F., Hu, S., Cherry, A. M., Robbins, R. C., Longaker, M. T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908450106 · Cited by 504
“Furthermore, iPS cells can be readily derived from adult hASCs in a feeder-free condition, thereby eliminating potential variability caused by using feeder cells. hASCs can be safely and readily isolated from adult humans in large quantities without extended time for expansion, are easy to maintain in culture, and the…”
BackgroundReprogramming of murine and human somatic cells using a single polycistronic vector
Carey, B. W., Markoulaki, S., Hanna, J., Saha, K., Gao, Q., Mitalipova, M., & Jaenisch, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811426106 · Cited by 503
Harnessing the potential of induced pluripotent stem cells for regenerative medicine
Wu, S. M., & Hochedlinger, K. (2011) · Nature Cell Biology · doi:10.1038/ncb0511-497 · Cited by 506
“Different groups subsequently repeated these findings with human cell”
Hentze, H., Soong, P. L., Wang, S. T., Phillips, B. W., Putti, T. C., & Dunn, N. R. (2009) · Stem Cell Research · doi:10.1016/j.scr.2009.02.002 · Cited by 501
“For example, amniotic stem cell lines were recently shown to exhibit incomplete pluripotency, while human-induced pluripotent stem (iPS) cells readily formed bona fide teratomas in SCID mice (De Coppi et al., 2007; Takahashi et al., 2007; Yu et al., 2007).”
Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells
Chen, Y.-C., Hsu, H.-S., Chen, Y.-W., Tsai, T.-H., How, C.-K., Wang, C.-Y., Hung, S.-C., Chang, Y.-L., Tsai, M.-L., Lee, Y.-Y., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002637 · Cited by 508
“Using the siRNA method with lentiviral vector for knockdown of Oct-4 expression in LC-CD133 + , our data showed that the treatment of Oct-4 siRNA can block the sphere formation of LC-CD133 + and further facilitate LC-CD133 + to differentiate into LC-CD133 2 (Fig.”
BackgroundMethodInterspecies Chimerism with Mammalian Pluripotent Stem Cells
Wu, J., Platero-Luengo, A., Sakurai, M., Sugawara, A., Gil, M. A., Yamauchi, T., Suzuki, K., Bogliotti, Y. S., Cuello, C., Morales Valencia, M., et al. (2017) · Cell · doi:10.1016/j.cell.2016.12.036 · Cited by 500
“…induced pluripotent stem cells (iPSCs) from somatic cells through cellular reprograming (Takahashi et al., 2007; Park et al., 2008; Wernig et al., 2007; Yu et al., 2007; Aasen et al., 2008), has revolutionized the way we study human development and is heralding a new age of regenerative medicine.”
BackgroundGene Targeting of a Disease-Related Gene in Human Induced Pluripotent Stem and Embryonic Stem Cells
Zou, J., Maeder, M. L., Mali, P., Pruett-Miller, S. M., Thibodeau-Beganny, S., Chou, B.-K., Chen, G., Ye, Z., Park, I.-H., Daley, G. Q., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.05.023 · Cited by 509
UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells
Zhang, J., Khvorostov, I., Hong, J. S., Oktay, Y., Vergnes, L., Nuebel, E., Wahjudi, P. N., Setoguchi, K., Wang, G., Do, A., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.401 · Cited by 505
Dedifferentiation and reprogramming: origins of cancer stem cells
Friedmann‐Morvinski, D., & Verma, I. M. (2014) · EMBO reports · doi:10.1002/embr.201338254 · Cited by 495
“The idea that degenerative as well as genetic diseases can be treated by regenerating the diseased organ or replacing the “damaged” cells with “healthy” new cells is fast becoming a reality since the first isolation of human embryonic stem cells (ESCs) and generation of induced pluripotent stem cells (iPSCs) from term…”
RAB31 marks and controls an ESCRT-independent exosome pathway
Wei, D., Zhan, W., Gao, Y., Huang, L., Gong, R., Wang, W., Zhang, R., Wu, Y., Gao, S., & Kang, T. (2021) · Cell Research · doi:10.1038/s41422-020-00409-1 · Cited by 492
Panopoulos, A. D., Yanes, O., Ruiz, S., Kida, Y. S., Diep, D., Tautenhahn, R., Herrerías, A., Batchelder, E. M., Plongthongkum, N., Lutz, M., et al. (2012) · Cell Research · doi:10.1038/cr.2011.177 · Cited by 495
Nanog, Pou5f1 and SoxB1 activate zygotic gene expression during the maternal-to-zygotic transition
Lee, M. T., Bonneau, A. R., Takacs, C. M., Bazzini, A. A., DiVito, K. R., Fleming, E. S., & Giraldez, A. J. (2013) · Nature · doi:10.1038/nature12632 · Cited by 503
Alzheimer’s disease and its treatment by different approaches: A review
Srivastava, S., Ahmad, R., & Khare, S. K. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113320 · Cited by 467
Biophysical regulation of epigenetic state and cell reprogramming
Downing, T. L., Soto, J., Morez, C., Houssin, T., Fritz, A., Yuan, F., Chu, J., Patel, S., Schaffer, D. V., & Li, S. (2013) · Nature Materials · doi:10.1038/nmat3777 · Cited by 496
Blastocyst-like structures generated from human pluripotent stem cells
Yu, L., Wei, Y., Duan, J., Schmitz, D. A., Sakurai, M., Wang, L., Wang, K., Zhao, S., Hon, G. C., & Wu, J. (2021) · Nature · doi:10.1038/s41586-021-03356-y · Cited by 501
Kawamura, M., Miyagawa, S., Miki, K., Saito, A., Fukushima, S., Higuchi, T., Kawamura, T., Kuratani, T., Daimon, T., Shimizu, T., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.084343 · Cited by 495
Heng, J.-C. D., Feng, B., Han, J., Jiang, J., Kraus, P., Ng, J.-H., Orlov, Y. L., Huss, M., Yang, L., Lufkin, T., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2009.12.009 · Cited by 489
“Besides the four reprogramming factors discovered in the groundbreaking study of Yamanaka, other factors such as NANOG and LIN28 were also found to participate in reprogramming (Yu et al., 2007).”
BackgroundGeneration of pluripotent stem cells from adult human testis
Conrad, S., Renninger, M., Hennenlotter, J., Wiesner, T., Just, L., Bonin, M., Aicher, W., Bühring, H.-J., Mattheus, U., Mack, A., et al. (2008) · Nature · doi:10.1038/nature07404 · Cited by 496
RetractedLive cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells
Chan, E. M., Ratanasirintrawoot, S., Park, I.-H., Manos, P. D., Loh, Y.-H., Huo, H., Miller, J. D., Hartung, O., Rho, J., Ince, T. A., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1580 · Cited by 487
“Because of the lack of selectable markers that have proven so valuable in studies of mouse cell reprogramming, human iPS cells have been isolated in previous studies based on the distinct morphology of human ES cell colonie”
BackgroundDeng, J., Shoemaker, R., Xie, B., Gore, A., LeProust, E. M., Antosiewicz-Bourget, J., Egli, D., Maherali, N., Park, I.-H., Yu, J., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1530 · Cited by 491
“We performed the methylation assay on three sets of fibroblasts and iPS cells from three laboratories: IMR/IMR90-iP”
Self-citationHematopoietic and Endothelial Differentiation of Human Induced Pluripotent Stem Cells
Choi, K.-D., Yu, J., Smuga-Otto, K., Salvagiotto, G., Rehrauer, W. M., Vodyanik, M. A., Thomson, J. L., & Slukvin, I. I. (2009) · Stem Cells · doi:10.1002/stem.20080922 · Cited by 492
Self-citationInduced Pluripotent Stem Cells Meet Genome Editing
Hockemeyer, D., & Jaenisch, R. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.04.013 · Cited by 499
“…equally potent in reprogramming cells to a pluripotent state, providing valuable insights into the transcriptional pluripotency networks and how cells establish pluripotency (Buganim et al., 2012) (Apostolou and Hochedlinger, 2013; Park et al., 2008; Takahashi and Yamanaka, 2015; Yu et al., 2007).”
BackgroundEfficient generation of hepatocyte-like cells from human induced pluripotent stem cells
Song, Z., Cai, J., Liu, Y., Zhao, D., Yong, J., Duo, S., Song, X., Guo, Y., Zhao, Y., Qin, H., et al. (2009) · Cell Research · doi:10.1038/cr.2009.107 · Cited by 499
(2011) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199568765.001.0001 · Cited by 349
Guidelines and Techniques for the Generation of Induced Pluripotent Stem Cells
Maherali, N., & Hochedlinger, K. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.11.008 · Cited by 486
Generation of Induced Pluripotent Stem Cells from Human Cord Blood
Haase, A., Olmer, R., Schwanke, K., Wunderlich, S., Merkert, S., Hess, C., Zweigerdt, R., Gruh, I., Meyer, J., Wagner, S., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.08.021 · Cited by 481
“Induction of pluripotent stem cells Cells were transduced with concentrated lentiviral vectors pSIN-EF2-Oct4-Pur, pSIN-EF2Sox2-Pur, pSIN-EF2-Nanog-Pur, and pSIN-EF2-LIN28-Pur (MOI 20) in fibroblast or endothelial culture medium containing 8 µg / ml polybrene (Sigma-Aldrich).”
BackgroundInfluentialEpigenetic dynamics of stem cells and cell lineage commitment: digging Waddington's canal
Hemberger, M., Dean, W., & Reik, W. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2727 · Cited by 476
“, and OCT4, SOX2, NANOG and the Caenorhabditis elegans LIN-28 homologue in human fibroblast”
BackgroundThe HD iPSC Consortium (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.04.027 · Cited by 490
“Reprogramming was conducted by lentiviral transduction of six transcription factors (Oct4, Sox2, Klf4, cMyc, Nanog, and Lin28) as previously described (Yu et al., 2007).”
BackgroundMethodInfluentialInduced pluripotent stem cells — opportunities for disease modelling and drug discovery
Grskovic, M., Javaherian, A., Strulovici, B., & Daley, G. Q. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3577 · Cited by 474
Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells
Hagan, J. P., Piskounova, E., & Gregory, R. I. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1676 · Cited by 491
“For example, Lin28 was identified as one of four factors that reprogram human fibroblasts into induced pluripotent stem (iPS) cell”
Generation and assembly of human brain region-specific three-dimensional cultures
Sloan, S. A., Andersen, J., Pașca, A. M., Birey, F., & Pașca, S. P. (2018) · Nature Protocols · doi:10.1038/s41596-018-0032-7 · Cited by 490
Generation of Functional Murine Cardiac Myocytes From Induced Pluripotent Stem Cells
Mauritz, C., Schwanke, K., Reppel, M., Neef, S., Katsirntaki, K., Maier, L. S., Nguemo, F., Menke, S., Haustein, M., Hescheler, J., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.778795 · Cited by 488
Derivation of induced pluripotent stem cells from pig somatic cells
Ezashi, T., Telugu, B. P. V. L., Alexenko, A. P., Sachdev, S., Sinha, S., & Roberts, R. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905284106 · Cited by 484
“As the ectopically expressed reprogramming genes may cause imbalance in the pluripotency network and even influence the ability of reprogrammed cells to differentiate optimally (29, 54, 59), ideally the genes should either not be permitted to integrate in the first place (60–62) or excised once reprogramming has been…”
BackgroundRamalho-Santos, J., Varum, S., Amaral, S., Mota, P. C., Sousa, A. P., & Amaral, A. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp016 · Cited by 482
Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications
Doss, M. X., & Sachinidis, A. (2019) · Cells · doi:10.3390/cells8050403 · Cited by 456
Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties
Leung, E. L.-H., Fiscus, R. R., Tung, J. W., Tin, V. P.-C., Cheng, L. C., Sihoe, A. D.-L., Fink, L. M., Ma, Y., & Wong, M. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014062 · Cited by 473
“Expression of the key ‘stemness’ genes of embryonic (ES) and inducedpluripotent stem (iPS) cells OCT4 and BMI1 [9,10] have been found in CSC from different cancers [11,12].”
BackgroundInfluentialChromatin connectivity maps reveal dynamic promoter–enhancer long-range associations
Zhang, Y., Wong, C.-H., Birnbaum, R. Y., Li, G., Favaro, R., Ngan, C. Y., Lim, J., Tai, E., Poh, H. M., Wong, E., et al. (2013) · Nature · doi:10.1038/nature12716 · Cited by 478
A small molecule that directs differentiation of human ESCs into the pancreatic lineage
Chen, S., Borowiak, M., Fox, J. L., Maehr, R., Osafune, K., Davidow, L., Lam, K., Peng, L. F., Schreiber, S. L., Rubin, L. L., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.154 · Cited by 478
Darabi, R., Arpke, R. W., Irion, S., Dimos, J. T., Grskovic, M., Kyba, M., & Perlingeiro, R. C. R. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.02.015 · Cited by 481
“…iPS cells through the use of safer transient vectors (Kaji et al., 2009; Okita et al., 2008; Stadtfeld et al., 2008; Woltjen et al., 2009; Yu et al., 2009), transduction of recombinant proteins (Kim et al., 2009; Zhou et al., 2009), or the use of synthetic modified mRNA (Warren et al.,…”
Meyer, J. S., Howden, S. E., Wallace, K. A., Verhoeven, A. D., Wright, L. S., Capowski, E. E., Pinilla, I., Martin, J. M., Tian, S., Stewart, R., et al. (2011) · Stem Cells · doi:10.1002/stem.674 · Cited by 469
“Reprogramming was performed as previously described [23] using lentiviral vectors expressing OCT4, SOX2, NANOG, LIN28, c-MYC, and KLF4.”
Self-citationNarazaki, G., Uosaki, H., Teranishi, M., Okita, K., Kim, B., Matsuoka, S., Yamanaka, S., & Yamashita, J. K. (2008) · Circulation · doi:10.1161/circulationaha.108.769562 · Cited by 476
Chu, L.-F., Leng, N., Zhang, J., Hou, Z., Mamott, D., Vereide, D. T., Choi, J., Kendziorski, C., Stewart, R., & Thomson, J. A. (2016) · Genome Biology · doi:10.1186/s13059-016-1033-x · Cited by 477
“When applied WaveCrest to the scRNA-seq DE differentiation time course data, we selected the genes of interest by combining empirical results from SCPattern and prior knowledge [1, 2, 5, 7, 9, 20].”
BackgroundMethodSelf-citationAberrant Regulation and Function of MicroRNAs in Cancer
Adams, B. D., Kasinski, A. L., & Slack, F. J. (2014) · Current Biology · doi:10.1016/j.cub.2014.06.043 · Cited by 471
“While normally only expressed at high levels during development, these small proteins are unique in their ability to convert human somatic cells to pluripotency when co-expressed with the reprogramming factors OCT4, NANOG and SOX2 [33].”
Repair of Acute Myocardial Infarction by Human Stemness Factors Induced Pluripotent Stem Cells
Nelson, T. J., Martinez-Fernandez, A., Yamada, S., Perez-Terzic, C., Ikeda, Y., & Terzic, A. (2009) · Circulation · doi:10.1161/circulationaha.109.865154 · Cited by 471
Adult mice generated from induced pluripotent stem cells
Boland, M. J., Hazen, J. L., Nazor, K. L., Rodriguez, A. R., Gifford, W., Martin, G., Kupriyanov, S., & Baldwin, K. K. (2009) · Nature · doi:10.1038/nature08310 · Cited by 463
Formative pluripotency: the executive phase in a developmental continuum
Smith, A. (2017) · Development · doi:10.1242/dev.142679 · Cited by 474
“Human PSCs, whether embryo-derived or generated by molecular reprogramming (Takahashi et al., 2007; Yu et al., 2007), are conventionally maintained in similar culture conditions as EpiSCs, and do not tolerate 2iLIF.”
BackgroundReprogramming of Human Peripheral Blood Cells to Induced Pluripotent Stem Cells
Staerk, J., Dawlaty, M. M., Gao, Q., Maetzel, D., Hanna, J., Sommer, C. A., Mostoslavsky, G., & Jaenisch, R. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.06.002 · Cited by 459
“A major step to achieve this was the recent discovery that ectopic expression of defined transcription factors induces pluripotency in somatic cells (Lowry et al., 2008; Park et al., 2008b; Takahashi et al., 2007; Yu et al., 2007).”
BackgroundBesnard, E., Babled, A., Lapasset, L., Milhavet, O., Parrinello, H., Dantec, C., Marin, J.-M., & Lemaitre, J.-M. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2339 · Cited by 440
iPS Cells Can Support Full-Term Development of Tetraploid Blastocyst-Complemented Embryos
Kang, L., Wang, J., Zhang, Y., Kou, Z., & Gao, S. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.07.001 · Cited by 457
“…al., 2009; Hanna et al., 2007; Park et al., 2008; Soldner et al., 2009; Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Wernig et al., 2008; Yu et al., 2007). iPSCs can functionally differentiate into all cell lineages within chimeric mice, including germ cells that can ultimately give…”
BackgroundAltered proliferation and networks in neural cells derived from idiopathic autistic individuals
Marchetto, M. C., Belinson, H., Tian, Y., Freitas, B. C., Fu, C., Vadodaria, K. C., Beltrao-Braga, P. C., Trujillo, C. A., Mendes, A. P. D., Padmanabhan, K., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.95 · Cited by 466
Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells
Liang, J., Wan, M., Zhang, Y., Gu, P., Xin, H., Jung, S. Y., Qin, J., Wong, J., Cooney, A. J., Liu, D., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1736 · Cited by 453
Deconstructing Stem Cell Tumorigenicity: A Roadmap to Safe Regenerative Medicine
Knoepfler, P. S. (2009) · Stem Cells · doi:10.1002/stem.37 · Cited by 456
The Tumorigenicity of Human Embryonic Stem Cells
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)00005-5 · Cited by 451
Eminli, S., Foudi, A., Stadtfeld, M., Maherali, N., Ahfeldt, T., Mostoslavsky, G., Hock, H., & Hochedlinger, K. (2009) · Nature Genetics · doi:10.1038/ng.428 · Cited by 442
“Resulting primary (11) iPS cells were injected into mouse blastocysts.”
BackgroundThe LIN28/let-7 Pathway in Cancer
Balzeau, J., Menezes, M. R., Cao, S., & Hagan, J. P. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00031 · Cited by 447
Physical Cues of Biomaterials Guide Stem Cell Differentiation Fate
Higuchi, A., Ling, Q.-D., Chang, Y., Hsu, S.-T., & Umezawa, A. (2013) · Chemical Reviews · doi:10.1021/cr300426x · Cited by 458
Targeting Notch to Target Cancer Stem Cells
Pannuti, A., Foreman, K., Rizzo, P., Osipo, C., Golde, T., Osborne, B., & Miele, L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2823 · Cited by 450
“Stemness can be restored in normal fibroblasts by expression of Oct4, Sox2, Nanog, and LIN28 (19), or Oct3/4, sox2, Klf4, and c-Myc (20).”
BackgroundLin28: Primal Regulator of Growth and Metabolism in Stem Cells
Shyh-Chang, N., & Daley, G. Q. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.03.005 · Cited by 458
Wang, T., Chen, K., Zeng, X., Yang, J., Wu, Y., Shi, X., Qin, B., Zeng, L., Esteban, M. A., Pan, G., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.10.005 · Cited by 458
“Somatic cell fate can be reset into a pluripotent-like state by introducing defined factors known to regulate pluripotency, including Oct4, Sox2, Klf4, c-Myc, Nanog, and Lin28 (Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Wernig et al., 2007; Yu et al., 2007).”
BackgroundActivin/Nodal signalling maintains pluripotency by controlling Nanog expression
Vallier, L., Mendjan, S., Brown, S., Chng, Z., Teo, A., Smithers, L. E., Trotter, M. W. B., Cho, C. H.-H., Martinez, A., Rugg-Gunn, P., et al. (2009) · Development · doi:10.1242/dev.033951 · Cited by 451
“…the function of pluripotency factors in each of these pluripotent states will be crucial to achieving control over the differentiation of human pluripotent cells, whether derived from mammalian embryos or by inducing pluripotency in cells of somatic origin (Takahashi et al., 2007; Yu et al., 2007).”
BackgroundMir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state
Lin, S.-L., Chang, D. C., Chang-Lin, S., Lin, C.-H., Wu, D. T. S., Chen, D. T., & Ying, S.-Y. (2008) · RNA · doi:10.1261/rna.1162708 · Cited by 451
“Additional iPS cell lines have continued to be developed from human embryonic fibroblasts and primary dermal fibroblast cultures using a similar approach (Yu et al. 2007; Park et al. 2008).”
MethodA graphene-based platform for induced pluripotent stem cells culture and differentiation
Chen, G.-Y., Pang, D. W.-P., Hwang, S.-M., Tuan, H.-Y., & Hu, Y.-C. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.071 · Cited by 456
“reprogramming factors while obviating the need to destroy embryos [10,11].”
Guenther, M. G., Frampton, G. M., Soldner, F., Hockemeyer, D., Mitalipova, M., Jaenisch, R., & Young, R. A. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.06.015 · Cited by 456
“Mammalian cells can be directly reprogrammed into induced pluripotent stem cells (iPSCs) by introduction of defined sets of transcriptional regulators (Takahashi and Yamanaka, 2006; Maherali et al., 2007; Nakagawa et al., 2008; Okita et al., 2007; Takahashi et al., 2007; Wernig et al., 2007; Yu et al., 2007; Aoi et al…”
BackgroundHiggs, D. R., Engel, J. D., & Stamatoyannopoulos, G. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60283-3 · Cited by 434
Bauwens, C. L., Peerani, R., Niebruegge, S., Woodhouse, K. A., Kumacheva, E., Husain, M., & Zandstra, P. W. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0183 · Cited by 447
The Role of miRNAs in Regulating Gene Expression Networks
Gurtan, A. M., & Sharp, P. A. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.03.007 · Cited by 443
“Demonstrating a role for mammalian Lin-28 in maintaining “stemness”, overexpression of Lin-28, in combination with Oct4, Sox2, and Nanog, promotes induction of pluripotency in somatic fibroblasts.(124) Inhibition of let-7 by overexpression of Lin-28b in adult hematopoietic stem cells results in the reprogramming of th…”
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications
Cerneckis, J., Cai, H., & Shi, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01809-0 · Cited by 452
“3,5 These combinations of reprogramming factors remain widely used today, whereas Gurdon and Yamanaka were awarded the 2012 Nobel Prize in Physiology or Medicine for their discoveries.”
BackgroundMethodInduced pluripotent stem cells: the new patient?
Bellin, M., Marchetto, M. C., Gage, F. H., & Mummery, C. L. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3448 · Cited by 431
Fazzio, T. G., Huff, J. T., & Panning, B. (2008) · Cell · doi:10.1016/j.cell.2008.05.031 · Cited by 442
Kashyap, V., Rezende, N. C., Scotland, K. B., Shaffer, S. M., Persson, J. L., Gudas, L. J., & Mongan, N. P. (2009) · Stem Cells and Development · doi:10.1089/scd.2009.0113 · Cited by 436
Zhang, J., Klos, M., Wilson, G. F., Herman, A. M., Lian, X., Raval, K. K., Barron, M. R., Hou, L., Soerens, A. G., Yu, J., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.273144 · Cited by 445
“1 mmol/L β-mercaptoethanol (Sigma), supplemented with 100 ng/mL zebrafish basic fibroblast growth factor (bFGF; purified from a bacterial expression system by us) for iPSCs, and 4 ng/mL human recombinant bFGF (Invitrogen) for ESCs as described previously.(21,24,25) Cell lines were used continuously between passages of…”
MethodSelf-citationRoles of TGF-β family signaling in stem cell renewal and differentiation
Watabe, T., & Miyazono, K. (2009) · Cell Research · doi:10.1038/cr.2008.323 · Cited by 428
Generation of Functional Human Hepatic Endoderm From Human Induced Pluripotent Stem Cells
Sullivan, G. J., Hay, D. C., Park, I.-H., Fletcher, J., Hannoun, Z., Payne, C. M., Dalgetty, D., Black, J. R., Ross, J. A., Samuel, K., et al. (2010) · Hepatology · doi:10.1002/hep.23335 · Cited by 445
A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types
Wernig, M., Lengner, C. J., Hanna, J., Lodato, M. A., Steine, E., Foreman, R., Staerk, J., Markoulaki, S., & Jaenisch, R. (2008) · Nature Biotechnology · doi:10.1038/nbt1483 · Cited by 441
Yang, X., Rodriguez, M., Pabon, L., Fischer, K. A., Reinecke, H., Regnier, M., Sniadecki, N. J., Ruohola-Baker, H., & Murry, C. E. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.04.005 · Cited by 431
“Undifferentiated human IMR90-induced pluripotent stem cells, originally derived from lungfibroblasts [18] (JamesA.”
Cancer stem cells and chemoresistance: The smartest survives the raid
Zhao, J. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.02.008 · Cited by 437
“of the “terminally differentiated” cells by re-activation of a few reprogramming transcription factors (RPFs) (244-247) as illustrated above in Figure 1.”
Singh, V. K., Kalsan, M., Kumar, N., Saini, A., & Chandra, R. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00002 · Cited by 416
“In regenerative medicine the injured or degenerated tissues are repaired by the generation of those tissues with the help of iPSCs in labs and then transplanting them to the site of injury or degeneration.”
BackgroundMethodInfluentialWnt Signaling Promotes Reprogramming of Somatic Cells to Pluripotency
Marson, A., Foreman, R., Chevalier, B., Bilodeau, S., Kahn, M., Young, R. A., & Jaenisch, R. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.06.019 · Cited by 436
Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells
Zwi, L., Caspi, O., Arbel, G., Huber, I., Gepstein, A., Park, I.-H., & Gepstein, L. (2009) · Circulation · doi:10.1161/circulationaha.109.868885 · Cited by 435
Saitou, M., & Yamaji, M. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008375 · Cited by 418
Induction of Expansion and Folding in Human Cerebral Organoids
Li, Y., Muffat, J., Omer, A., Bosch, I., Lancaster, M. A., Sur, M., Gehrke, L., Knoblich, J. A., & Jaenisch, R. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2016.11.017 · Cited by 436
“However, recent advances in human pluripotent stem cell technology (Takahashi et al., 2007; Yu et al., 2007) and 3D culture systems (Lancaster et al.”
Osakada, F., Jin, Z.-B., Hirami, Y., Ikeda, H., Danjyo, T., Watanabe, K., Sasai, Y., & Takahashi, M. (2009) · Journal of Cell Science · doi:10.1242/jcs.050393 · Cited by 426
“…can reprogram somatic cells into induced pluripotent stem (iPS) cells (Nakagawa et al., 2008; Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007). iPS cells have been shown to be functionally equivalent to ES cells, as they express ES cell markers, have similar gene expression…”
BackgroundDerivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem Cells
Monzel, A. S., Smits, L. M., Hemmer, K., Hachi, S., Moreno, E. L., van Wuellen, T., Jarazo, J., Walter, J., Brüggemann, I., Boussaad, I., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.03.010 · Cited by 435
“With the development of methods to generate induced pluripotent stem cells (iPSCs) from somatic cells (Takahashi and Yamanaka, 2006; Yu et al., 2007), human cells with the potential to generate all body cell types in vitro became available.”
MethodBiomaterials for Bone Regenerative Engineering
Yu, X., Tang, X., Gohil, S. V., & Laurencin, C. T. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201400760 · Cited by 418
Stem cell‐based cell therapy in neurological diseases: A review
Kim, S. U., & de Vellis, J. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22054 · Cited by 426
“…there has been an exciting development in generation of a new class of pluripotent stem cells, induced pluripotent cells (iPS cells), from adult somatic cells such as skin fibroblasts by introduction of embryogenesis-related genes (Takahashi et al., 2007; Yu et al., 2007; Park et al., 2008).”
BackgroundCellular plasticity and the neuroendocrine phenotype in prostate cancer
Davies, A. H., Beltran, H., & Zoubeidi, A. (2018) · Nature Reviews Urology · doi:10.1038/nrurol.2018.22 · Cited by 431
Maury, Y., Côme, J., Piskorowski, R. A., Salah-Mohellibi, N., Chevaleyre, V., Peschanski, M., Martinat, C., & Nedelec, S. (2015) · Nature Biotechnology · doi:10.1038/nbt.3049 · Cited by 408
Taylor, C. J., Peacock, S., Chaudhry, A. N., Bradley, J. A., & Bolton, E. M. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.07.014 · Cited by 428
“…(iPSCs) can be generated successfully from a variety of readily obtainable adult tissues, including skin and peripheral blood, and have the capacity for extensive expansion in vitro, while retaining their pluripotency (Takahashi et al., 2007; Yu et al., 2007; Park et al., 2008; Eisenstein, 2010).”
BackgroundStructures, Biosynthesis, and Functions of Gangliosides-an Overview
Yu, R. K., Tsai, Y.-T., Ariga, T., & Yanagisawa, M. (2011) · Journal of Oleo Science · doi:10.5650/jos.60.537 · Cited by 416
Metadata
- Authors
- Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., Slukvin, I. I., & Thomson, J. A.
- Affiliations
- WiCell (US)
- Genome Center of Wisconsin, Madison, WI 53706–1580, USA.
- Venue
- Science
- Published
- 2007-12-21
- Volume
- 318
- Issue
- 5858
- Pages
- 1917-1920
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2142046859
- Cited by
- 10,310
- References
- 14
- Citations by year
- 2026: 167 · 2025: 219 · 2024: 285 · 2023: 322 · 2022: 332 · 2021: 506 · 2020: 441 · 2019: 443 · 2018: 452 · 2017: 515 · 2016: 580 · 2015: 652 · 2014: 692 · 2013: 816 · 2012: 940
- FWCI
- 271.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (P20GM069981)
- National Center for Research Resources (P51RR000167)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- induced pluripotent stem cells, somatic cell nuclear transfer, reprogramming factors, Oct4, SOX2, Nanog, Lin28, pluripotency, telomerase activity, germ layer differentiation, karyotype, disease models, drug development, transplantation medicine
- MeSH terms
- Nanog Homeobox Protein, Animals, Cell Differentiation, Cell Line, DNA-Binding Proteins, Fetus, Fibroblasts, Humans, Infant, Newborn, Karyotyping, Teratoma, Transcription Factors, Transduction, Genetic, Mice, SCID, RNA-Binding Proteins, Homeodomain Proteins, Transgenes, Oligonucleotide Array Sequence Analysis, HMGB Proteins, Stem Cell Transplantation, Pluripotent Stem Cells, Cell Shape, Cell Proliferation, Octamer Transcription Factor-3, Mice, Embryonic Stem Cells, SOXB1 Transcription Factors, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.